相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Baseline differences in the SAVOR trial
H. J. Luijendijk et al.
DIABETES OBESITY & METABOLISM (2015)
Important outcome predictors showed greater baseline heterogeneity than age in two systematic reviews
Laura Clark et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
The Mortality Risk of Conventional Antipsychotics in Elderly Patients: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Tessa A. Hulshof et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2015)
The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials
Hui Ma et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Mortality Risk after Dementia Diagnosis by Dementia Type and Underlying Factors: A Cohort of 15,209 Patients based on the Swedish Dementia Registry
Sara Garcia-Ptacek et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
A methodological review of recent meta-analyses has found significant heterogeneity in age between randomized groups
Laura Clark et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool
Mark S. Corbett et al.
RESEARCH SYNTHESIS METHODS (2014)
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
Jelena Savovic et al.
SYSTEMATIC REVIEWS (2014)
Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review
Dallas P. Seitz et al.
INTERNATIONAL PSYCHOGERIATRICS (2013)
Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data
Richard D. Riley et al.
STATISTICS IN MEDICINE (2013)
OSELTAMIVIR AND FLU Methodological concerns about studies on oseltamivir for flu
Mark H. Ebell
BMJ-BRITISH MEDICAL JOURNAL (2013)
Factors that influence survival in a probable Alzheimer disease cohort
Susan D. Rountree et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults A Systematic Review and Meta-analysis
Alicia Ruelaz Maher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease
Joel E. Streim et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study
D. Paleacu et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
The impact of trial baseline imbalances should be considered in systematic reviews: a methodological case study
Rebecca Trowman et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: A multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses
Jacobo E. Mintzer et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Quetiapine for agitation or psychosis in patients with dementia and parkinsonism
Roger Kurlan et al.
NEUROLOGY (2007)
Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study
Kate X. Zhong et al.
CURRENT ALZHEIMER RESEARCH (2007)
Mortality in elderly dementia patients treated with risperidone
Martin Haupt et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S. Schneider et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled clinical trial
Pierre N. Tariot et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
LS Schneider et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Risperidone in the treatment of psychosis of Alzheimer disease: Results from a prospective clinical trial
J Mintzer et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia
S Carson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia
J Kennedy et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2005)
Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials
LS Schneider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Aripiprazole for the treatment of psychosis in patients with Alzheimer's Disease - A randomized, placebo-controlled study
P De Deyn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
C Ballard et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Survival following dementia onset: Alzheimer's disease and vascular dementia
AL Fitzpatrick et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease
PP De Deyn et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
A structural approach to selection bias
MA Hernán et al.
EPIDEMIOLOGY (2004)
Estimating prognosis for nursing home residents with advanced dementia
SL Mitchell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data
MJ Sweeting et al.
STATISTICS IN MEDICINE (2004)
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia
H Brodaty et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities -: A double-blind, randomized, placebo-controlled trial
JS Street et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment
H Allain et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
